Asset profile

VY1706 · Voyager Therapeutics (VYGR)

Indication
Alzheimer’s disease
CompanyVYGRVoyager Therapeutics

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson'…

On the calendar

Nothing scheduled in this window.

Timeline

Newest first.

VY1706 · Voyager Therapeutics (VYGR) — FDA Timeline & Readiness Checklist | SimianX AI